So pumped up to work along Eur. Fdn. for the Study of Chronic Liver Failure Jonel Trebicka vice-secretary EASLnews Debbie Shawcross and Alexander Gerbes about novel therapies and approaches to tackle #aclf . We highlighted U.S. FDA BEST framework to tackle future biomarker development in ACLF ncbi.nlm.nih.gov/books/NBK32679…

#GUTImage from the #LeadingArticle paper by Byrne et al entitled

'Thyroid hormone receptor-beta agonists: new MASLD therapies on the horizon' via

bit.ly/3vdfuJH

#MASLD

Waiting for other agencies to follow, looking forwards to treat patients outside trials bit.ly/3Pmyqwr #FDAApproval #NASH

Daniel J Drucker Gut Journal Thanks Daniel J Drucker and the Gutsy Journal Gut Journal and Emad El-Omar Dufour for featuring our paper on it's cover --- We can predict MASH resolution with an AUROC of 0.83 using MRI-PDFF, ALT and AST Naga Chalasani Quentin M. Anstee Alina Allen Vijay Shah Chris Thompson, MD

A pleasure to give the annual prize of the Swiss Foundation against Liver Cancer to Dr Melloul and Dr Martin for their work on HCC burden and liver resection. ⁦Emmanuel Melloul⁩ ⁦Foundation Cancer du Foie⁩ ⁦CHUV / Centre hospitalier universitaire vaudois⁩

Free Debrief on HCC with Anna Saborowski, K. Kelley, R. Finn, R. Lencioni, P. Galle on 29th of February Program&registration l1nq.com/188kp Foundation Cancer du Foie

#GUTImage from the paper by Evelyn Medawar et al on

'Prebiotic diet changes neural correlates of food decision-making in overweight adults: a randomised controlled within-subject cross-over trial' via

bit.ly/3O07jGF

@witte1veronica #Prebiotic #Diet

Join us on the 30. November 2023 for our Symposium '2023 a pivotal year for NASH' you find the agenda here: swissnashfoundation.org/events/ #nash #nafld #LiverTwitter #LiverX

#GUTAbstract by Zhang & Terry Cheuk-Fung Yip on

'Clinical care pathway to detect advanced liver disease in patients with type 2 diabetes through automated fibrosis score calculation...' via bit.ly/49b1uz4

Paper: bit.ly/49aAArq

Grace Wong Lee-Ling Lim Vincent Wong

#GUTImage from the paper by Cho, Ang and Quek et al entitled

'Global prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus: an updated systematic review and meta-analysis' via

bit.ly/3rOKMot

Aung Hlaing Bwa MBBS, FRCP Anand V Kulkarni Karn Wijarnpreecha Rohit Loomba

Congratulations Johann von Felden for being a UEG Rising Star Awardee 2023! The liver rocks 🌟🌟🌟 UEG Week EASLnews

Tribute to Prof. Gustav Paumgartner (1933-2023) easl.eu/news/obituaryp…

Pegozafermin effects on top of GLP-1 therapy ⁦Rohit Loomba⁩ ⁦Swiss NASH Foundation⁩ ⁦EASL Education⁩

Prof Bataller sharing his experience in alcohol-associated liver disease ⁦Ramon Bataller⁩ ⁦Susana Rodrigues⁩

Dufour Foundation Cancer du Foie Excellent speakers 👌
Strongly recommend to participate!

This Thursday we will have our #HCC Day 2023 with plenty of talks about current research. Register for free here 👇🏻

register here to attend online the #HCC 2023 Day --> us06web.zoom.us/webinar/regist… #HCC #LiverTwitter

Sunanda Kane M.D. Atoosa Rabiee Gut Journal Nancy Reau ACOG ACG American Gastroenterological Association (AGA) Emad El-Omar That's why boss Emad El-Omar gets Gut Journal such a high IF paper, in collaboration with other liver experts Alexander Gerbes Dufour #robertthimme #fabienzoulim

2022 ends with a good news. Resmetirom achieved both endpoints in MAESTRO-NASH phase 3 trial: NASH resolution 30% vs 10% and fibrosis improvement 26% vs 14% in placebo bit.ly/3Wm39uQ Rohit Loomba Quentin M. Anstee Jörn Schattenberg